News tagged with glaxosmithkline

Related topics: diabetes , heart attack , food and drug administration , vaccine

Anti-ageing drug breakthrough

Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher. The work, published in the March 8 issue of Science, finally proves that a single anti-ageing enzyme in the ...

Mar 08, 2013
popularity 4.9 / 5 (16) | comments 2

Flu vaccine linked to narcolepsy in under 30s: study

A vaccine used in Sweden in the 2009-2010 "swine flu" pandemic is linked to a higher risk of the sleeping disorder narcolepsy among under 30s, and not just children and teens as previously thought, a Swedish study showed ...

Mar 26, 2013
popularity 5 / 5 (2) | comments 0

New drugs, diagnostic approved for advanced melanoma

(HealthDay)—Two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved by the U.S. Food and Drug Administration to treat advanced melanoma, the most dangerous form of skin cancer.

May 29, 2013
popularity 5 / 5 (2) | comments 0

GlaxoSmithKline posts rising Q3 profits

British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rose seven percent, boosted by growth across its main pharmaceuticals, vaccines and consumer healthcare divisions.

Oct 26, 2011
popularity 5 / 5 (1) | comments 1

GlaxoSmithKline

GlaxoSmithKline plc (LSE: GSK NYSE: GSK) is a United Kingdom-based pharmaceutical, biological, and healthcare company. GSK is the world's second largest pharmaceutical company and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

This text uses material from Wikipedia licensed under CC BY-SA